Versigent (VGNT) Q1 2026 earnings review
Solid Revenue, But Spin-Off Costs Obscure Profitability
Versigent's inaugural quarter as a standalone company presents a stark contrast between top-line resilience and bottom-line friction. Revenue grew 9% YoY (3% adjusted) to $2.2 billion, defying a broader slowdown in global auto production. However, profitability suffered. Net income dropped 18% YoY to $78 million, and Free Cash Flow reversed into the red at $(30) million, dragged down by $72 million in restructuring and separation costs. Despite the immediate margin compression, management aggressively signaled confidence by announcing a dividend and $250 million buyback, banking on a steep operational acceleration in H2 to meet their ambitious FY26 cash flow targets.
🐂 Bull Case
Versigent delivered 3% adjusted revenue growth driven by NA and APAC volume strength, outperforming the underlying decline in global automotive production.
Initiating a $0.13 quarterly dividend and a $250 million share repurchase program on day one of independence projects extreme confidence in future cash generation.
🐻 Bear Case
Despite higher volumes, Adjusted EBITDA margin contracted by 60 bps to 9.2%, exposing vulnerability to commodity costs and foreign exchange headwinds.
The transition to independence was expensive. Free Cash Flow reversed from $3 million last year to $(30) million, putting intense pressure on the remaining quarters to hit the $250 million FY26 midpoint guidance.
⚖️ Verdict: ⚪
Neutral. The core business is executing well on the top line, capturing market share despite a tough macro environment. However, the heavy spin-off costs, ballooning debt, and immediate margin compression show the growing pains of becoming a standalone public entity.
Key Themes
Market Share Gains in a Weak Macro
Versigent is successfully decoupling from the broader industry malaise. Management noted that growth was driven by higher volumes in North America and Asia Pacific, specifically highlighting 'stronger customer demand despite lower global automotive production.' This indicates successful penetration of their electrical distribution systems into winning platforms.
The 'Cash-Generative' Contradiction
The CFO explicitly called Versigent a 'highly-engineered, cash-generative business,' yet the actual data tells a reversing story. Free Cash Flow plunged to $(30) million in Q1 (from $3 million a year ago). While $26 million in separation costs and $46 million in restructuring explain the miss, operating cash flow itself also decelerated to $36 million (down 10% YoY). The gap between narrative and Q1 reality is wide.
Commodity and FX Pressures Crushing Margins
The business showed negative operating leverage in Q1. While reported revenue grew 9%, Adjusted EBITDA grew only 2.5%, resulting in a margin compression from 9.8% to 9.2%. Management directly blamed 'headwinds related to commodity costs and foreign exchange impacts,' suggesting they currently lack the pricing power to pass these costs through to automotive OEMs fully.
Immediate Shareholder Value Pivot
Rather than hoarding cash during a complex spin-off, the Board authorized a $0.13 quarterly dividend and a $250 million open-market share repurchase program. This acts as a primary driver for the stock, establishing a yield floor and providing buying support during the typical post-spin-off shareholder base transition.
High-Voltage Architecture Demand
Versigent continues to leverage its foundational IP in 'low- and high-voltage electrical architectures.' As the industry transitions toward electric vehicles and increasingly complex in-cabin electronics, the demand for sophisticated signal, power, and data distribution systems serves as a multi-year secular tailwind driving the company's outperformance against baseline auto production.
Sudden Debt Burden and Interest Drag
The balance sheet radically transformed overnight. Long-term debt skyrocketed from $3 million at the end of 2025 to $2.07 billion. Consequently, interest expense more than doubled to $5 million in Q1, and this is just a partial-quarter effect. The $1.9 billion cash distribution paid back to parent Aptiv heavily leveraged Versigent right out of the gate, which will act as a permanent drag on Net Income.
Other KPIs
Combined Q1 restructuring ($46M) and separation costs ($26M) equaled nearly the entirety of the company's Net Income ($78M). These non-recurring items severely depressed GAAP profitability and pushed free cash flow negative. Investors must monitor whether 'restructuring' becomes a permanent fixture in the earnings adjustments.
Accelerating. CapEx nearly doubled YoY from $37 million in 25Q1. This elevated investment rate ($240M implied for the full year) is eating into free cash flow and suggests the standalone entity requires heavier capital intensity than it did while operating inside Aptiv.
Guidance
Decelerating. The midpoint of $9.25 billion implies roughly 2% adjusted revenue growth for the year, which is a step down from the 3% adjusted growth delivered in Q1. This likely bakes in continued sluggishness in global automotive production for the remainder of 2026.
Accelerating. The midpoint of $990 million implies a full-year margin of 10.7%. Given that Q1 printed at just 9.2%, management is heavily relying on a steep margin acceleration in Q2-Q4 to hit this target. This requires commodity headwinds to abate or pricing actions to kick in.
Accelerating dramatically. After a $(30) million cash burn in Q1, the company must generate roughly $280 million in positive FCF over the next three quarters just to hit the midpoint. This assumes a sharp drop-off in separation costs and normalized working capital.
Key Questions
The Bridge to 10.7% Margin
Q1 Adjusted EBITDA margin compressed to 9.2%. Your FY guidance implies a 10.7% margin. What are the specific operational levers—pricing, cost cuts, or commodity normalization—that will drive this 150 bps acceleration over the next three quarters?
Restructuring Cost Timeline
Restructuring costs nearly tripled YoY to $46 million. Is this a one-time peak associated with the spin-off, or should investors expect an elevated run-rate of restructuring charges throughout FY26?
Capital Allocation Priority
With the balance sheet now carrying over $2 billion in long-term debt, how do you prioritize the newly announced $250 million share repurchase program versus rapid deleveraging?